SCHEMBL30848613

SCHEMBL30848613

COc1ccccc1C(=O)NC1(C)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.61
CNR2 P34972 1/20 0.61
CTSD P07339 1/20 0.58
STAT3 P40763 1/20 0.55
RAB9A P51151 3/20 0.54
NPC1 O15118 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
KCNK3 O14649 1/20 0.53
KCNK9 Q9NPC2 1/20 0.53
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 1/20 0.52
HPGD P15428 2/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20068936 0.89 HCN1 (0.55) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL21652028 0.85 CHRM5 (0.52) FAAHCNR2CTSDSMN1; SMN2MEN1
SCHEMBL20147583 0.85 HCN1 (0.57) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL20147987 0.85 FAAH (0.50) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL30855446 0.83 FAAH (0.59) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL30848550 0.79 FAAH (0.56) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL30848628 0.79 FAAH (0.56) FAAHCNR2CTSDSTAT3RAB9A
SCHEMBL30848467 0.78 CNR2 (0.89) FAAHCNR2CTSDSTAT3MEN1
SCHEMBL397839 0.78 HPGD (0.51) RAB9ANPC1SMN1; SMN2HPGDGAA
SCHEMBL30848679 0.77 CNR2 (0.64) FAAHCNR2CTSDSTAT3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118043327-A FGFR inhibitors and methods of use thereof 思康睿奇(上海)药业有限公司 2024-05-14 CN claimed
CN-118043327-A FGFR inhibitors and methods of use thereof 思康睿奇(上海)药业有限公司 2024-05-14 CN disclosed